Literature DB >> 8750586

Activities of adenosine deaminase, 5'-nucleotidase, guanase, and cytidine deaminase enzymes in cancerous and non-cancerous human breast tissues.

O Canbolat1, I Durak, R Cetin, M Kavutcu, S Demirci, S Oztürk.   

Abstract

We measured activities of some DNA turnover enzymes in 9 breast tissues with stage II cancer, 6 breast tissues with stage IIIa cancer, and 9 non-cancerous adjacent breast tissues from the same patients with stage II cancer. We found higher Adenosine Deaminase (ADA) and 5'-Nucleotidase (5'NT) and lower Guanase (GUA) activities in the cancerous tissues compared with the non-cancerous ones. No meaningful differences were however found between Cytidine Deaminase (CD) activities. Regarding the correlation analysis, positive correlations were established between ADA and 5'NT activities of the cancerous tissues (r = 0.45 for the tissues with stage II and r = 0.60 for the tissues with stage IIIa cancer). No meaningful correlations were however found between other enzyme activities. Relating to activity ratios, no meaningful differences were found between ADA/5'NT values in the tissues. GUA/CD ratios were however lower and the other ratios higher in the cancerous tissues. Results indicated that ADA and 5'NT activities increased and GUA activity decreased in the cancerous breast tissues but CD activities did not change in the tissues affected. It has been suggested that increased ADA and 5'NT together with decreased GUA activities might be a physiologic attempt of the cancer cells to provide more substrates needed by cancer cells to accelerate the salvage pathway activity. Furthermore, high ADA activity might also play part in the detoxication process of high amounts of toxic adenosine and deoxyadenosine substrates produced from accelerated purine metabolism in the cancerous tissues.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8750586     DOI: 10.1007/bf01806500

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  16 in total

1.  Evaluation of a simple method for the measurement of cytidine deaminase in serum and comparison with a reference method.

Authors:  P W Thompson; I T James; L Rowell; D D Jones
Journal:  Clin Chim Acta       Date:  1990-11-15       Impact factor: 3.786

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Serum cytidine deaminase levels after withdrawal of non-steroidal anti-inflammatory treatment in rheumatoid arthritis.

Authors:  P W Thompson; J R Kirwan; D D Jones; H L Currey
Journal:  Ann Rheum Dis       Date:  1988-04       Impact factor: 19.103

4.  Overproduction of adenine deoxynucleosides and deoxynucletides in adenosine deaminase deficiency with severe combined immunodeficiency disease.

Authors:  J Donofrio; M S Coleman; J J Hutton; A Daoud; B Lampkin; J Dyminski
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

5.  Ecto-5'nucleotidase and adenosine deaminase activities of lymphoid cells.

Authors:  J Dornand; J C Bonnafous; J Favero; J C Mani
Journal:  Biochem Med       Date:  1982-10

6.  Two forms of adenosine deaminase in pig epidermis.

Authors:  H Iizuka; H Koizumi; K Kamigaki; T Aoyagi; Y Miura
Journal:  J Dermatol       Date:  1981-04       Impact factor: 4.005

7.  Purine salvage enzyme activities in normal and neoplastic human tissues.

Authors:  M Camici; M G Tozzi; S Allegrini; A Del Corso; O Sanfilippo; M G Daidone; C De Marco; P L Ipata
Journal:  Cancer Biochem Biophys       Date:  1990-07

8.  Resistance of an adenosine kinase-deficient human lymphoblastoid cell line to effects of deoxyadenosine on growth, S-adenosylhomocysteine hydrolase inactivation, and dATP accumulation.

Authors:  M S Hershfield; N M Kredich
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205

9.  Adenosine deaminase activity in patients with carcinoma of the bladder.

Authors:  G Sufrin; G L Tritsch; A Mittelman; G P Murphy
Journal:  J Urol       Date:  1978-03       Impact factor: 7.450

10.  Adenosine deaminase, 5' nucleotidase, xanthine oxidase, superoxide dismutase, and catalase activities in cancerous and noncancerous human laryngeal tissues.

Authors:  I Durak; A C Işik; O Canbolat; O Akyol; M Kavutçu
Journal:  Free Radic Biol Med       Date:  1993-12       Impact factor: 7.376

View more
  17 in total

1.  A novel transition state analog inhibitor of guanase based on azepinomycin ring structure: Synthesis and biochemical assessment of enzyme inhibition.

Authors:  Saibal Chakraborty; Niti H Shah; James C Fishbein; Ramachandra S Hosmane
Journal:  Bioorg Med Chem Lett       Date:  2010-11-27       Impact factor: 2.823

2.  Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells.

Authors:  Li Wang; Xuerui Zhou; Tingting Zhou; Dong Ma; Sifeng Chen; Xiuling Zhi; Lianhua Yin; Zhimin Shao; Zhouluo Ou; Ping Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-02       Impact factor: 4.553

3.  Diminution in adenine nucleotide hydrolysis by platelets and serum from rats submitted to Walker 256 tumour.

Authors:  Andréia Buffon; Vanessa B Ribeiro; Alessandra S Schanoski; João J F Sarkis
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

4.  Guanine deaminase functions as dihydropterin deaminase in the biosynthesis of aurodrosopterin, a minor red eye pigment of Drosophila.

Authors:  Jaekwang Kim; Sang Ick Park; Chiyoung Ahn; Heuijong Kim; Jeongbin Yim
Journal:  J Biol Chem       Date:  2009-06-30       Impact factor: 5.157

5.  Bioorthogonal labeling cell-surface proteins expressed in pancreatic cancer cells to identify potential diagnostic/therapeutic biomarkers.

Authors:  Randy S Haun; Charles M Quick; Eric R Siegel; Ilangovan Raju; Samuel G Mackintosh; Alan J Tackett
Journal:  Cancer Biol Ther       Date:  2015-07-15       Impact factor: 4.742

6.  Overexpression of CD73 in prostate cancer is associated with lymph node metastasis.

Authors:  Qing Yang; Jun Du; Lingling Zu
Journal:  Pathol Oncol Res       Date:  2013-05-08       Impact factor: 3.201

7.  The comparison of adenosine deaminase activity values with polymerase chain reaction results in patients with tuberculosis.

Authors:  O Canbolat; S Ulusdoyuran; G Ozgen; I Ceyhan; F Gümüşlü; A Akbay
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

8.  CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression.

Authors:  Dachuan Jin; Jie Fan; Long Wang; Linda F Thompson; Aijie Liu; Benjamin J Daniel; Tahiro Shin; Tyler J Curiel; Bin Zhang
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

9.  Identification of Serum Biomarkers for Gastric Cancer Diagnosis Using a Human Proteome Microarray.

Authors:  Lina Yang; Jingfang Wang; Jianfang Li; Hainan Zhang; Shujuan Guo; Min Yan; Zhenggang Zhu; Bin Lan; Youcheng Ding; Ming Xu; Wei Li; Xiaonian Gu; Chong Qi; Heng Zhu; Zhifeng Shao; Bingya Liu; Sheng-Ce Tao
Journal:  Mol Cell Proteomics       Date:  2015-11-23       Impact factor: 5.911

10.  Serum Adenosine Deaminase Levels and Human Papillomavirus as Prognostic and Predictive Factors for Laryngeal and Pharyngeal Carcinomas.

Authors:  C Chandrakiran; Thanu Jogy; Sanjay B Patil
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.